ArticleBMC immunology2023

Efficacy and safety of immune checkpoint inhibitors in Proficient Mismatch Repair (pMMR)/ Non-Microsatellite Instability-High (non-MSI-H) metastatic colorectal cancer: a study based on 39 cohorts incorporating 1723 patients.

Qing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.